← All companies
CRNX
Crinetics Pharmaceuticals, Inc.
$83.76
+0.24 +0.29%
Key statistics
from XBRL data in SEC filingsMarket cap
$8.88B
Revenue (TTM)
$42.2M
Net income (TTM)
-$502M
EPS (TTM)
$-5.05
P/E ratio
—
Dividend yield
—
Free cash flow
-$384M
Cash
$55.5M
Total assets
$1.32B
Gross margin
—
52-week range
$25.83 – $84.00
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-06-30
Aug 3, 2026
8-K
Results of operations (earnings release)
Aug 3, 2026
8-K
Entered a material agreement; Director or officer change
Jul 10, 2026
8-K
Entered a material agreement; Other events
Jul 6, 2026
8-K
Shareholder vote results
Jun 22, 2026
10-Q
Quarter ended 2026-03-31
May 7, 2026
8-K
Results of operations (earnings release)
May 7, 2026
8-K
Director or officer change
Apr 10, 2026
8-K
Director or officer change
Mar 23, 2026
8-K
Changed accountants
Mar 3, 2026
10-K
Fiscal year ended 2025-12-31
Feb 26, 2026
8-K
Results of operations (earnings release)
Feb 26, 2026
8-K
Director or officer change
Jan 26, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Jan 13, 2026
8-K
Other events
Jan 7, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure; Other events
Jan 5, 2026
8-K
Director or officer change
Dec 17, 2025
10-Q
Quarter ended 2025-09-30
Nov 6, 2025
8-K
Results of operations (earnings release)
Nov 6, 2025
8-K
Regulation FD disclosure; Other events
Sep 26, 2025
10-Q
Quarter ended 2025-06-30
Aug 7, 2025
8-K
Results of operations (earnings release)
Aug 7, 2025
8-K
Regulation FD disclosure
Jun 30, 2025
8-K
Regulation FD disclosure; Other events
Jun 26, 2025
8-K
Shareholder vote results
Jun 12, 2025
10-Q
Quarter ended 2025-03-31
May 8, 2025
8-K
Results of operations (earnings release)
May 8, 2025
8-K
Director or officer change
Apr 4, 2025
10-K
Fiscal year ended 2024-12-31
Feb 27, 2025
8-K
Results of operations (earnings release)
Feb 27, 2025
8-K
Director or officer change; Regulation FD disclosure
Feb 24, 2025
8-K
Regulation FD disclosure
Jan 14, 2025
8-K
Regulation FD disclosure; Other events
Jan 10, 2025
8-K
Director or officer change; Regulation FD disclosure
Dec 16, 2024
8-K
Other events
Dec 9, 2024
10-Q
Quarter ended 2024-09-30
Nov 12, 2024
8-K
Results of operations (earnings release)
Nov 12, 2024
8-K
Director or officer change
Oct 16, 2024
8-K
Other events
Oct 9, 2024
8-K
Other events
Sep 26, 2024